Millions Logo
home>US Stocks>Minerva Neurosciences
NERV
Minerva NeurosciencesHealthcare
$2.39$-1.58 (-39.90%)in 1 year
As on 13 Nov 2026 at 02:29NASDAQ
52 Week Low: $1.9652 Week High: $8.80

Minerva Neurosciences Share Price Today

Minerva Neurosciences opened lower at $2.53, compared with its previous close of $2.56. In the last trading session, the stock traded between $2.38 and $2.53. It showed a downward intraday trend.

Return calculator

Time Period

An investment of $100 made 5 years ago in Minerva Neurosciences is now worth

$ 22.09

Resulting in a loss of

$ 77.91 (77.91%)

Invest with $1

Note: Past profits do not guarantee future returns.

Analyst Overview

Buy

Rating from 2 Analysts

Buy
50%
Hold
50%
Sell
0%

Markets Today

Today's Change

$-0.17 (-6.80%)

Day High

$2.53

Day Low

$2.38

Day Open

$2.53

Prev Close

$2.56

Volume

61,148

1W Return

-6.28%

1M Return

-16.98%

3M Return

-44.67%

6M Return

-57.62%

1Y Return

-39.90%

Fundamentals

Market Cap ($ Mn)

119

PE Ratio

-

PB Ratio

-

PEG Ratio

-

ROE

-

ROCE

-685.10%

EPS (TTM)

$2.00

Investment Returns

1 Week

-6.28%

1 Month

-16.98%

3 Months

-44.67%

6 Months

-57.62%

9 Months

-62.31%

Financials

Quarterly
All values in $ Mn
0.0

Jun 25
0.0

Sep 25
0.0

Dec 25
0.0

Mar 26
0.0

Jun 26
0.0

Sep 26

Updates

28Aug

Minerva Neurosciences to present at Wells Fargo and Cantor conferences

Minerva Neurosciences management to attend two investor conferences in New York. Wells Fargo conference participation includes 1x1 meetings on September 8. Cantor conference features a fireside chat from 2:45 pm to 3:15 pm EDT on September 9. Live webcast and replay available on company website.

2mo ago
7Aug

Minerva Neurosciences Q2 adjusted EPS beats estimates on warrant gain

Minerva Neurosciences reported Q2 2026 adjusted EPS of $(0.10), beating the $(0.12) estimate by 9.09%. GAAP net income reached $17.5 million on a $27.6 million warrant liability gain, while adjusted net loss widened to $7.8 million amid rising R&D costs for its roluperidone Phase 3 trial.

3mo ago
10Jun

Minerva launches AI marketing platform with $20M funding

Minerva launched an AI platform for consumer marketing leaders with $20 million in funding from The General Partnership, 8VC, Lingotto Innovation, Topology Ventures, and NBA Investments. The platform unifies first-party data and uses AI agents to optimize campaigns, reporting early improvements of 3.4x in paid media ROAS. The company also announced a collaboration with OpenAI to develop agentic tools.

5mo ago

Similar Stocks

StockLTPChange %Market CapPE
$547.03-0.16%$1,38,692.89M31.55
$61.05+0.38%$1,31,510.31M14.39
$248.69-0.85%$1,00,625.20M-
$959.41+4.73%$97,505.80M19.64
$977.58+0.62%$61,476.10M38.99
$419.98-0.95%$46,108.31M65.60
$180.70-6.40%$39,083.96M-
$53.87-0.37%$33,618.11M26.24
$70.01+0.81%$31,173.07M32.37
$41.85+1.60%$30,322.88M-
$120.75+1.05%$26,490.14M-
$122.27+1.64%$24,922.54M15.85